Vol. 123, No. 1 (Supplement) 2018
Supplement abstract

Mitochondrial involvement in fibromyalgia and melatonin protective effect

Francesca Bonomini
Anatomy and Physiopathology Division, Department of Clinical and Experimental Sciences, University of Brescia, Brescia, Italia
Gaia Favero
Anatomy and Physiopathology Division, Department of Clinical and Experimental Sciences, University of Brescia, Brescia, Italia
Claudio Lonati
Anatomy and Physiopathology Division, Department of Clinical and Experimental Sciences, University of Brescia, Brescia, Italia
Lorena Giugno
Anatomy and Physiopathology Division, Department of Clinical and Experimental Sciences, University of Brescia, Brescia, Italia
Lorenzo Franceschetti
Anatomy and Physiopathology Division, Department of Clinical and Experimental Sciences, University of Brescia, Brescia, Italia
Rita Rezzani
Anatomy and Physiopathology Division, Department of Clinical and Experimental Sciences, University of Brescia, Brescia, Italia

Published 2018-12-30

Keywords

  • Fibromyalgia,
  • Mitochondria,
  • Melatonin,
  • Oxidative stress

How to Cite

Bonomini, F., Favero, G., Lonati, C., Giugno, L., Franceschetti, L., & Rezzani, R. (2018). Mitochondrial involvement in fibromyalgia and melatonin protective effect. Italian Journal of Anatomy and Embryology, 123(1), 26. https://doi.org/10.13128/ijae-11309

Abstract

Fibromyalgia (FM) is considered as one of the most common musculoskeletal disorder asso- ciated with a chronic pain condition. The principal characteristic of this condition is a wide- spread pain often associated with sleep disorders, fatigue and consequent anxiety and/or depression. Due to the prevalence of this pathology, recent studies aimed at increasing under- standing of both its pathogenesis and treatment have been conducted, but the knowledge is far behind other chronic illnesses in both mechanism understanding as well as appropriate thera- peutic approaches [1]. Recent studies reported that in FM patients the metabolism of a pow- erful antioxidant that is Coenzyme Q10 (CoQ10), called also ubiquinone, is altered showing a new potential marker for this disorder. For study FM several potential animal models have been described, among that reserpine-induced myalgia (RIM) rats are considered a putative model of this pathology showing musculoskeletal alterations and also depressive-like behav- iours. Recent evidences suggest that melatonin, an indoleamine with multitasking properties, among which anti-inflammatory and anti-oxidant effects, may be suitable in FM treatment [2].

In this study, we hypothesized that dietary melatonin administration in RIM animal model would support anti-inflammatory and anti-oxidant response in skeletal muscles reducing so the FM symptoms. In particular we focalized our attention to mitochondrial involvement investi- gating the roles of CoQ10, mitofusin 2 (MFN2) and peroxisome proliferator activated receptor gamma coactivator 1 alpha (PGC1α) expression.

Our results showed that melatonin modulates mitochondria homeostasis and oxidative stress in RIM rats.

In summary this study showed that melatonin could be a potential tool in the prevention and treatment of FM symptoms.

Acknowledgment. Sincere thanks to Flamma S.p.A.-Italy (www.flammagroup.com) for cour- teously providing the melatonin and for the precious economic support to this study.

Metrics

Metrics Loading ...